Page last updated: 2024-08-17

carbostyril and Conduct Disorder

carbostyril has been researched along with Conduct Disorder in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assuncao-Talbott, S; Blumer, J; Boulton, DW; Findling, RL; Iwamoto, T; Kauffman, R; Kollia, G; Kornhauser, DM; Mallikaarjun, S; McQuade, RD; Sahasrabudhe, V; Salazar, DE; Sallee, FR; Vachharajani, NN	1
Barnett, M; Calarge, C; Holman, T; Kolar, A; Kuperman, S; Perry, P	1
Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A	1

Trials

1 trial(s) available for carbostyril and Conduct Disorder

Article	Year
An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2011, Volume: 23, Issue:4 Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Conduct Disorder; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2011

Article

Year

An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2011, Volume: 23, Issue:4

Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Conduct Disorder; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome

2011

Other Studies

2 other study(ies) available for carbostyril and Conduct Disorder

Article	Year
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:4 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting	2009
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2008

Article

Year

An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.

Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:4

Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting

2009

Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.

Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2

Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2008